| Recombinant human acid alpha-glucosidase | Myozyme® (Genzyme Corporation) | For use in patients with Pompe disease (GAA deficiency). Alglucosidase alfa has been shown to improve ventilator-free survival in patients with infantile onset Pompe disease as compared to an untreated historical control, whereas use of Alphaglucosidase | Daily Med
|